Literature DB >> 26047254

Pyoderma gangrenosum with increased levels of serum cytokines.

Kana Kozono1, Takeshi Nakahara1,2, Satoko Kikuchi1,3, Eriko Itoh1,2, Makiko Kido-Nakahara1, Masutaka Furue1.   

Abstract

A 66-year-old woman presented after an episode of accidental trauma with a painful ulcer on her scalp which rapidly enlarged in size, accompanied by central necrosis and undermining ulceration. The patient's past history was negative for underlying systemic disease, although she had had a similar post-traumatic intractable leg ulcer 3 years prior, which was unresponsive to surgical management but successfully treated with systemic steroids. A biopsied specimen from the scalp showed marked neutrophilic infiltrates in the dermis, compatible with a diagnosis of pyoderma gangrenosum (PG). The large ulcerative lesion responded very well to oral steroid therapy, showing rapid epithelialization. Serum levels of granulocyte colony-stimulating factor and interleukin-6 were significantly elevated prior to treatment, with decrease to normal levels after treatment. Serum tumor necrosis factor (TNF)-α and granulocyte macrophage colony-stimulating factor levels were within normal limits. The significance and pathogenic role of cytokine burst in PG is reviewed and discussed.
© 2015 Japanese Dermatological Association.

Entities:  

Keywords:  cytokine; granulocyte colony-stimulating factor; interleukin-6; neutrophilic dermatoses; pyoderma gangrenosum

Mesh:

Substances:

Year:  2015        PMID: 26047254     DOI: 10.1111/1346-8138.12970

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  2 in total

1.  Pyoderma gangrenosum preceding the onset of extranodal natural killer/T-cell lymphoma: A case report.

Authors:  Ting-Hua Yang; Chung-Hong Hu; Hsiou-Hsin Tsai
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

Review 2.  Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.

Authors:  Carlo Alberto Maronese; Matthew A Pimentel; May M Li; Alex G Ortega-Loayza; Angelo Valerio Marzano; Giovanni Genovese
Journal:  Am J Clin Dermatol       Date:  2022-05-24       Impact factor: 6.233

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.